<code id='61D94A2045'></code><style id='61D94A2045'></style>
    • <acronym id='61D94A2045'></acronym>
      <center id='61D94A2045'><center id='61D94A2045'><tfoot id='61D94A2045'></tfoot></center><abbr id='61D94A2045'><dir id='61D94A2045'><tfoot id='61D94A2045'></tfoot><noframes id='61D94A2045'>

    • <optgroup id='61D94A2045'><strike id='61D94A2045'><sup id='61D94A2045'></sup></strike><code id='61D94A2045'></code></optgroup>
        1. <b id='61D94A2045'><label id='61D94A2045'><select id='61D94A2045'><dt id='61D94A2045'><span id='61D94A2045'></span></dt></select></label></b><u id='61D94A2045'></u>
          <i id='61D94A2045'><strike id='61D94A2045'><tt id='61D94A2045'><pre id='61D94A2045'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:832
          Sen. Elizabeth Warren gestures with one hand during a hearing — insurance coverage from STAT
          Sen. Elizabeth Warren (D-Mass.) Kent Nishimura/Getty Images

          Senate Democrats on Thursday said Medicare should take more urgent and aggressive action to prevent health insurance companies from using artificial intelligence to unlawfully deny medical services.

          The Biden administration’s latest efforts to increase transparency into AI tools don’t go far enough to protect patients, the lawmakers said at a Senate Finance Committee hearing.

          advertisement

          Sen. Elizabeth Warren (D-Mass.), citing a STAT investigation, took particularly sharp aim at the use of algorithms to deny care within Medicare Advantage. STAT’s stories had found repeated denials of desperately ill patients by the nation’s largest insurers.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?
          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

          SusanGalbraith,AstraZeneca’sheadofcancerresearchanddevelopment,speaksataSTATeventin2023.MarieMillerf

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          STAT Summit: Michael J. Fox on progress in Parkinson's research

          STATWhenMichaelJ.FoxwasdiagnosedwithParkinson’sdiseaseatage29,hisclearestsymptomwasasmallone—hispink